KRAS Codon 59 Missense
Associated Genetic Biomarkers
KRAS Codon 59 Missense is present in 0.08% of AACR GENIE cases, with colon adenocarcinoma, colorectal adenocarcinoma, endometrial endometrioid adenocarcinoma, lung adenocarcinoma, and rectal adenocarcinoma having the greatest prevalence .
KRAS Codon 59 Missense serves as an inclusion eligibility criterion in 3 clinical trials, of which 2 are open and 1 is closed. Of the trials that contain KRAS Codon 59 Missense as an inclusion criterion, 1 is phase 1 (0 open) and 2 are phase 2 (2 open).
Trials with KRAS Codon 59 Missense in the inclusion eligibility criteria most commonly target colorectal carcinoma and colorectal adenocarcinoma .
Irinotecan, adavosertib, bevacizumab, binimetinib, and fluorouracil are the most frequent therapies in trials with KRAS Codon 59 Missense as an inclusion criteria .
Significance of KRAS Codon 59 Missense in Diseases
Colorectal Carcinoma +
KRAS is altered in 44.18% of colorectal carcinoma patients with KRAS Codon 59 Missense present in 0.24% of all colorectal carcinoma patients .
KRAS Codon 59 Missense is an inclusion criterion in 2 clinical trials for colorectal carcinoma, of which 1 is open and 1 is closed. Of the trials that contain KRAS Codon 59 Missense and colorectal carcinoma as inclusion criteria, 1 is phase 1 (0 open) and 1 is phase 2 (1 open) .
Colorectal Adenocarcinoma +
KRAS is altered in 44.33% of colorectal adenocarcinoma patients with KRAS Codon 59 Missense present in 0.25% of all colorectal adenocarcinoma patients .
KRAS Codon 59 Missense is an inclusion criterion in 1 clinical trial for colorectal adenocarcinoma, of which 1 is open and 0 are closed. Of the trial that contains KRAS Codon 59 Missense and colorectal adenocarcinoma as inclusion criteria, 1 is phase 2 (1 open) .
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.
Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.
4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.